title: Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice.
authors.affiliation: Department of Internal Medicine II, University of Kiel, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Zeis
authors.forename: L
authors.initials: L
authors.lastname: Uharek
authors.forename: B
authors.initials: B
authors.lastname: Glass
authors.forename: T
authors.initials: T
authors.lastname: Gaska
authors.forename: J
authors.initials: J
authors.lastname: Steinmann
authors.forename: W
authors.initials: W
authors.lastname: Gassmann
authors.forename: H
authors.initials: H
authors.lastname: Löffler
authors.forename: W
authors.initials: W
authors.lastname: Müller-Ruchholtz
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D002051:Burkitt Lymphoma / Q000628:therapy*; D003131:Combined Modality Therapy; D016130:Immunophenotyping; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014916:Whole-Body Irradiation
chemical_list: D007376:Interleukin-2